Ikelan

Atenolol, the active ingredient in Ikelan, is a beta blocker presented as an oral dosage form for oral use. It is used to manage high blood pressure, chest pain, and certain heart rhythm disorders in adult patients. GNH USA supplies Ikelan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Atenolol is employed in cardiovascular conditions that require reduction of heart workload and blood pressure. - Hypertension: lowers systolic and diastolic pressure to reduce cardiovascular risk. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Post‑myocardial infarction: helps prevent recurrent cardiac events by stabilising heart rate. - Cardiac arrhythmias: controls abnormal heart rhythms by slowing conduction through the AV node.

Atenolol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headed sensation, especially when standing quickly. - Cold extremities: reduced blood flow to hands and feet. - Bradycardia: slower than normal heart rate. - Gastrointestinal upset: nausea or mild abdominal discomfort. - Sleep disturbances: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Severe bradycardia: markedly slow heart rate requiring medical attention. - Heart block: impaired electrical conduction that can cause fainting. - Bronchospasm: tightening of airway muscles, particularly in patients with asthma. - Masked hypoglycemia: reduced warning signs of low blood sugar in diabetic patients. - Severe hypotension: dangerously low blood pressure leading to dizziness or shock. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

Before initiating atenolol therapy, consider the following safety measures. - Renal impairment: adjust dose or monitor renal function closely. - Hepatic impairment: use with caution and consider dose reduction. - Asthma or COPD: monitor for bronchospasm and respiratory difficulty. - Pregnancy Category D: avoid unless potential benefits outweigh risks. - Concomitant beta‑blockers: avoid additive cardiac depression. - Store at ambient temperature: keep in original container, protect from moisture and light.

Atenolol can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Verapamil or diltiazem: may cause severe bradycardia or heart block. - Clonidine: abrupt discontinuation can trigger rebound hypertension. - Insulin or sulfonylureas: may mask symptoms of hypoglycemia.

Moderate Interactions (Monitor Closely): - Other antihypertensives: combined effect may lead to excessive blood pressure reduction. - NSAIDs: can diminish atenolol’s blood‑pressure‑lowering efficacy.